IMU 0.00% 10.5¢ imugene limited

To add to this, when I spoke to Leslie she said she has been in...

  1. 1,460 Posts.
    lightbulb Created with Sketch. 275
    To add to this, when I spoke to Leslie she said she has been in contact with Genentech and they said if HER-Vaxx was proving to be successful in the clinic they would 100% want to partner with Imugene.

    Now if we have early signs Her-vaxx is beneficial on patients how long do you think it will be before we recieve offers from all the big pharma? They wouldn't take their time and miss out on the opportunity.

    Any positive signs of her-vaxx being successful is not just great for short term for SP it also means the imminent partnership is on the way.

    We also have the mimotope vaccine in the pipeline following behind her-vaxx which Leslie is just as excited about. As it's another B-cell vaccine her-vaxx will help with the valuation of this product as Imugene would have already proven if B-cell vaccines are superior to T-cells.

    Well worth a 2 year wait.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $768.4M
Open High Low Value Volume
10.5¢ 10.8¢ 10.0¢ $746.7K 7.120M

Buyers (Bids)

No. Vol. Price($)
161 9473412 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 259241 4
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
10.3¢
  Change
0.000 ( 2.40 %)
Open High Low Volume
10.3¢ 10.5¢ 10.3¢ 1930285
Last updated 15.59pm 29/03/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.